首页> 外文OA文献 >Cell Line Derived Multi-Gene Predictor of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: A Validation Study on US Oncology 02-103 Clinical Trial

【2h】

Cell Line Derived Multi-Gene Predictor of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: A Validation Study on US Oncology 02-103 Clinical Trial

机译：细胞系衍生的乳腺癌新辅助化疗病理反应的多基因预测因子：美国肿瘤学02-103临床试验的验证研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kui Shen; Yuan Qi; Nan Song; Chunqiao Tian; Shara D Rice; Michael J Gabrin; Stacey L Brower; William Fraser Symmans; Joyce A O’Shaughnessy; Frankie A Holmes; Lina Asmar; Lajos Pusztai;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cell Line Derived Multi-Gene Predictor of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: A Validation Study on US Oncology 02-103 Clinical Trial [J] . Kui Shen, Yuan Qi, Nan Song, BMC Medical Genomics . 2012,第1期

机译：细胞系衍生的乳腺癌新辅助化疗病理反应的多基因预测因子：美国肿瘤学02-103临床试验的验证研究
2. Tumour size is the only predictive factor of distant recurrence after pathological complete response to neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancers: A sub-study of EORTC 10994/BIG 1-00 phase III trial [J] . Fei F., Messina C., Slaets L., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2015,第3期

机译：肿瘤大小是可手术的或局部晚期乳腺癌的患者对新辅助化疗进行病理完全反应后远距离复发的唯一预测因素：EORTC 10994 / BIG 1-00 III期临床研究
3. Retraction--Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial. [J] . Bonnefoi H, Potti A, Delorenzi M, The lancet oncology . 2011,第2期

机译：撤回-预测乳腺癌对新辅助化疗反应的基因签名的验证：EORTC 10994 / BIG 00-01临床试验的一项子研究。
4. Usefulness of Adjunction of Digital Breast Tomosynthesis (DBT) to Full-Field Digital Mammography (FFDM) in Evaluation of Pathological Response after Neoadjuvant Chemotherapy (NAC) for Breast Cancer [C] . Nachiko Uchiyama, Takayuki Kinoshita, Takashi Hojo, Breast imaging . 2012

机译：全数字化乳腺X线摄影术（FFDM）与数字乳腺断层合成（DBT）的结合在评估乳腺癌新辅助化疗（NAC）后的病理反应中的作用
5. Development and Validation of a Nomogram to Predict Pathological Complete Response to Neoadjuvant Chemotherapy for Breast Cancer. [D] . Yang, Victoria Qi. 2015

机译：诺法图的开发和验证，以预测对乳腺癌新辅助化学疗法的病理完全反应。
6. Cell Line Derived Multi-Gene Predictor of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: A Validation Study on US Oncology 02-103 Clinical Trial [O] . Kui Shen, Yuan Qi, Nan Song, 2012

机译：细胞系衍生的乳腺癌新辅助化疗病理反应的多基因预测因子：美国肿瘤学02-103临床试验的验证研究
7. Cell Line Derived Multi-Gene Predictor of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: A Validation Study on US Oncology 02-103 Clinical Trial [O] . Shen Kui, Qi Yuan, Song Nan, 2012

机译：细胞系衍生的多基因预测因子对乳腺癌新辅助化疗的病理反应：美国肿瘤学的验证研究02-103临床试验

Cell Line Derived Multi-Gene Predictor of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: A Validation Study on US Oncology 02-103 Clinical Trial

著录项

引文网络

相似文献

相关主题

期刊订阅